PPA
ADVM

Parametric Portfolio Associates’s Adverum Biotechnologies ADVM Stock Holding History

Parametric Portfolio Associates’s Portfolio ADVM Stock Details ADVM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$172K Sell
13,164
-4,695
-26% -$68.7K ﹤0.01% 3474
2021
Q4 		$314K Buy
17,859
+7,839
+78% +$157K ﹤0.01% 3268
2021
Q3 		$217K Sell
10,020
-4,285
-30% -$109K ﹤0.01% 3407
2021
Q2 		$501K Buy
14,305
+10,017
+234% +$540K ﹤0.01% 3084
2021
Q1 		$423K Buy
4,288
+1,655
+63% +$199K ﹤0.01% 3573
2020
Q4 		$285K Buy
2,633
+537
+26% +$66.4K ﹤0.01% 3620
2020
Q3 		$216K Sell
2,096
-3,788
-64% -$567K ﹤0.01% 3625
2020
Q2 		$1.23M Buy
5,884
+3,350
+132% +$593K ﹤0.01% 2805
2020
Q1 		$248K Buy
2,534
+508
+25% +$59.2K ﹤0.01% 3460
2019
Q4 		$233K Buy
2,026
+532
+36% +$46.9K ﹤0.01% 3679
2019
Q3 		$81K Sell
1,494
-9,401
-86% -$1.06M ﹤0.01% 3864
2019
Q2 		$1.29M Buy
10,895
+9,807
+901% +$811K ﹤0.01% 2919
2019
Q1 		$57K Buy
+1,088
New +$44K ﹤0.01% 3875
2017
Q3 		– Sell
-1,571
Closed -$39K – 4024
2017
Q2 		$39K Sell
1,571
-3,751
-70% -$103K ﹤0.01% 3972
2017
Q1 		$144K Buy
5,322
+2,390
+82% +$68K ﹤0.01% 3661
2016
Q4 		$85K Sell
2,932
-516
-15% -$16.9K ﹤0.01% 3715
2016
Q3 		$142K Buy
3,448
+553
+19% +$21K ﹤0.01% 3638
2016
Q2 		$91K Buy
2,895
+602
+26% +$27.2K ﹤0.01% 3733
2016
Q1 		$119K Sell
2,293
-181
-7% -$10.1K ﹤0.01% 3838
2015
Q4 		$236K Buy
+2,474
New +$217K ﹤0.01% 3660

Other funds holding ADVM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
SFI
Sonic Fund II Honolulu, Hawaii $147M AUM 19.98% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Parametric Portfolio Associates's ADVM Position: Q1 2022 in Review

Parametric Portfolio Associates reduced its Adverum Biotechnologies (ADVM) stake by 26% in Q1 2022, selling an estimated $68.7K and leaving 13,164 shares worth $172K. The position accounts for ﹤0.01% of the portfolio, ranked #3474.

Parametric Portfolio Associates first reported a position in ADVM in Q4 2015 and has held it in 20 quarters since. The position peaked at $1.29M in Q2 2019. 92 funds tracked by Wall St. Rank hold ADVM as of Q1 2022.

  • Parametric Portfolio Associates held 13,164 shares of Adverum Biotechnologies worth $172K as of Q1 2022.
  • Parametric Portfolio Associates sold 4,695 Adverum Biotechnologies shares in Q1 2022, an estimated $68.7K.
  • Adverum Biotechnologies made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #3474 holding.
  • Parametric Portfolio Associates first reported a position in Adverum Biotechnologies in Q4 2015 and has held it in 20 quarters since.
  • Parametric Portfolio Associates's Adverum Biotechnologies position peaked at $1.29M in Q2 2019.
  • 92 funds tracked by Wall St. Rank held Adverum Biotechnologies as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.